2-Chloro-6-methylnicotinic acid

Catalog No.: 
ACMSBH856
CAS No.: 
30529-70-5
Molecular Formula: 
C7H6ClNO2
Molecular Weight: 
171.58
2-Chloro-6-methylnicotinic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$92.00In stockInquiry
500g98%$443.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-6-methylnicotinic acid
IUPAC Name2-chloro-6-methylnicotinic acid
MDL No.MFCD00134165
Molecular FormulaC7H6ClNO2
Molecular Weight171.58
SMILESO=C(O)C1=C(Cl)N=C(C)C=C1
InChI KeyACQXHCHKMFYDPM-UHFFFAOYSA-N
SynonymInChI=1/C7H6ClNO2/c1-4-2-3-5(7(10)11)6(8)9-4/h2-3H,1H3,(H,10,11 | TIMTEC-BB SBB003843 | UNII-6HJ6V3KP7Q | EINECS 250-229-7 | 2-Chloro-6-methyl nicotinic acid | SY009352 | 2-Chloro-6-methyl-3-pyridinecarboxylic acid | Zeolite, mordenite | MFCD00134165 | PS
CAS No.30529-70-5
PubChem CID121724

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMSBH856 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYIZQ061 route compound structure diagram
    ACYIZQ06138116-61-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMSBH856 route product structure diagram
    ACMSBH85630529-70-5In Stock
Inquiry

2. ACMSBH856 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJRKZ718 route compound structure diagram
    ACJRKZ71828900-10-9In Stock
  2. Then
  3. ACMSBH856 route product structure diagram
    ACMSBH85630529-70-5In Stock
Inquiry

3. ACMSBH856 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYLKC051 route compound structure diagram
    ACYLKC05153277-47-7In Stock
  2. Then
  3. ACMSBH856 route product structure diagram
    ACMSBH85630529-70-5In Stock
Inquiry

Comments (0)